Veterans Affairs to Permit Acquisition of Non-TAA-Compliant Drugs

by Reed Smith

In a significant policy reversal, the Department of Veterans Affairs (VA) has announced that it will require all covered drugs under the Veterans Health Care Act (VHCA) to be offered on Federal Supply Schedule (FSS) contracts, regardless of whether they meet the “country of origin” standards of the Trade Agreements Act (TAA).1 As discussed below, this policy shift will have an immediate impact on drug manufacturers and suppliers, especially the large number of drug manufacturers whose products are not TAA-compliant because of the use of active pharmaceutical ingredients (API) from India and China.

Under the TAA, government agencies, like the VA, are generally prohibited from procuring goods that are not made in the United States or in certain “designated countries.” Drugs manufactured with API from non-designated countries, like India or China, generally fall short of this standard and are not TAA-compliant. Unlike other government agencies, the VA has traditionally refused to make “non-availability” exceptions to the TAA’s country-of-origin requirement. As a result, drug manufacturers and suppliers have been blocked from offering non-TAA-compliant products on FSS contracts. That is no longer the case.

Under the new policy, the VA is now requiring that all covered drugs, regardless of county of origin, be available on a 65 I B FSS contract. And, for the first time, VA contracting officers will have the authority to issue “non-availability determinations,” permitting the VA to list non-TAA-compliant covered drugs on FSS contracts.

Contracting officers will consider two principal factors in making individual non-availability determinations. First, they will consider information provided by the offeror that neither the drug at-issue, nor similar products, is made in the United States or a “designated country” in sufficient quantity to fulfill the VA’s requirements. Second, they will consider the fact that the offered product is a covered drug under the VHCA and thus the manufacturer is required to make the drug available for procurement on its FSS contract.

The VA is implementing its new TAA policy on an expedited basis. Manufacturers must immediately list non-TAA-compliant covered drugs on their FSS contracts. Manufacturers that already have FSS contracts must submit a Request for Modification to add their non-TAA-compliant products. Companies that currently do not have an FSS contract, because all their covered drugs are non-TAA compliant, must enter into an Interim Agreement with the VA, enabling their covered drugs to be considered for an FSS contract. The key deadlines are as follows:

  • April 26, 2016: Submit Non-Federal Average Manufacturer Price (FAMP) information for TAA non-compliant covered drugs, if the company has not already been submitting Non-FAMPs for those products.
  • May 6, 2016: Submit signed mass modifications, requests for modification to add TAA non-compliant covered drugs, and Interim Agreements.
  • June 6, 2016: All TAA non-compliant drugs must be on an FSS contract or Interim Agreement.

In conjunction with its new policy, the VA has issued an FSS contract mass modification (Mass Modification 0004, Schedule 65 I B). The VA sent a link to this mass modification, along with addition procedures, via a “Constant Contact Notice” on April 19, 2016.

The VA’s new TAA policy is an important development for several reasons. First, it reconciles the longstanding legal conflict between the TAA’s country-of-origin requirements and the VHCA’s requirement to make all covered drugs available for purchase under the 65 I B Schedule program. Second, and perhaps most significantly, the new policy opens up FSS contracts to hundreds of pharmaceutical products that are manufactured with API from non-TAA designated countries. As a result, patients will have better access to a host of important drugs, and manufacturers of covered drugs will be able to participate more fully in a key market.

  1. See Announcement of VA’s Office of Acquisition and Logistics at

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Reed Smith | Attorney Advertising

Written by:

Reed Smith

Reed Smith on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.